Latest news with #Acrow
Yahoo
02-06-2025
- Business
- Yahoo
Acrow (ASX:ACF) shareholders have earned a 36% CAGR over the last five years
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But on the bright side, you can make far more than 100% on a really good stock. One great example is Acrow Limited (ASX:ACF) which saw its share price drive 255% higher over five years. So let's assess the underlying fundamentals over the last 5 years and see if they've moved in lock-step with shareholder returns. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). During five years of share price growth, Acrow achieved compound earnings per share (EPS) growth of 46% per year. This EPS growth is higher than the 29% average annual increase in the share price. So one could conclude that the broader market has become more cautious towards the stock. The image below shows how EPS has tracked over time (if you click on the image you can see greater detail). We consider it positive that insiders have made significant purchases in the last year. Even so, future earnings will be far more important to whether current shareholders make money. This free interactive report on Acrow's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. As it happens, Acrow's TSR for the last 5 years was 360%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence! Investors in Acrow had a tough year, with a total loss of 4.6% (including dividends), against a market gain of about 12%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 36%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 4 warning signs for Acrow you should be aware of. Acrow is not the only stock insiders are buying. So take a peek at this free list of small cap companies at attractive valuations which insiders have been buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21-04-2025
- Business
- Yahoo
ASX April 2025: Highlighting Three Stocks That May Be Trading Below Estimated Value
The Australian market has experienced a relatively stable day, with the ASX200 closing at 7,760 points and sectors such as Health Care showing positive movement while others like Staples lagged. In this context of fluctuating sector performances and strategic shifts among companies, identifying stocks that may be trading below their estimated value can present potential opportunities for investors looking to capitalize on market inefficiencies. Name Current Price Fair Value (Est) Discount (Est) Acrow (ASX:ACF) A$1.05 A$2.04 48.5% GenusPlus Group (ASX:GNP) A$2.63 A$5.15 48.9% Medical Developments International (ASX:MVP) A$0.485 A$0.89 45.5% Amaero (ASX:3DA) A$0.23 A$0.45 48.9% Genetic Signatures (ASX:GSS) A$0.44 A$0.84 47.6% Pantoro (ASX:PNR) A$2.72 A$5.36 49.2% Nuix (ASX:NXL) A$2.37 A$4.30 44.9% Integral Diagnostics (ASX:IDX) A$2.25 A$4.03 44.2% Electro Optic Systems Holdings (ASX:EOS) A$1.20 A$2.38 49.6% Select Harvests (ASX:SHV) A$5.41 A$9.62 43.8% Click here to see the full list of 36 stocks from our Undervalued ASX Stocks Based On Cash Flows screener. Here we highlight a subset of our preferred stocks from the screener. Overview: Corporate Travel Management Limited is a travel management solutions company that oversees the procurement and delivery of travel services across Australia and New Zealand, North America, Asia, and Europe, with a market cap of A$1.77 billion. Operations: The company generates revenue through its travel services across various regions, with A$60.96 million from Asia, A$126.20 million from Europe, A$319.90 million from North America, and A$181.43 million from Australia and New Zealand. Estimated Discount To Fair Value: 23.6% Corporate Travel Management is trading at A$12.57, 23.6% below its estimated fair value of A$16.46, making it potentially undervalued based on cash flows. Despite a drop in profit margins from 15.3% to 9.2%, earnings are projected to grow significantly at 21.3% annually, outpacing the Australian market's growth rate of 11.7%. Recent leadership changes aim to enhance operational efficiency and client growth as Jo Sully succeeds Greg McCarthy as CEO for Australia & New Zealand by June 2025. Our expertly prepared growth report on Corporate Travel Management implies its future financial outlook may be stronger than recent results. Unlock comprehensive insights into our analysis of Corporate Travel Management stock in this financial health report. Overview: Nick Scali Limited, with a market cap of A$1.44 billion, is involved in the sourcing and retailing of household furniture and related accessories across Australia, the United Kingdom, and New Zealand. Operations: The company's revenue is primarily derived from the retailing of furniture, amounting to A$492.63 million. Estimated Discount To Fair Value: 41% Nick Scali is trading at A$16.80, 41% below its estimated fair value of A$28.48, suggesting it may be undervalued based on cash flows. Despite a decline in net income to A$30.04 million for the half-year ending December 2024, forecasts indicate earnings growth of 12.3% annually, surpassing the Australian market average of 11.7%. The company maintains a reliable dividend yield of 3.57%, although dividends were reduced from previous levels due to decreased earnings per share. The growth report we've compiled suggests that Nick Scali's future prospects could be on the up. Click here to discover the nuances of Nick Scali with our detailed financial health report. Overview: Pantoro Limited, along with its subsidiaries, is involved in gold mining, processing, and exploration in Western Australia and has a market cap of A$1.05 billion. Operations: The company's revenue is primarily derived from the Norseman Gold Project, amounting to A$289.11 million. Estimated Discount To Fair Value: 49.2% Pantoro is trading at A$2.72, significantly below its estimated fair value of A$5.36, highlighting potential undervaluation based on cash flows. Recent production results show a 30% increase in gold output to 40,812 ounces with improved sales of A$153.43 million for the half-year ending December 2024. The company has turned profitable with net income of A$6.62 million and forecasts suggest robust earnings growth ahead, supported by ongoing drilling programs at the OK Underground Mine. Our comprehensive growth report raises the possibility that Pantoro is poised for substantial financial growth. Click here and access our complete balance sheet health report to understand the dynamics of Pantoro. Unlock our comprehensive list of 36 Undervalued ASX Stocks Based On Cash Flows by clicking here. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:CTD ASX:NCK and ASX:PNR. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
06-04-2025
- Business
- Yahoo
ASX Stocks That Could Be Undervalued In April 2025
In the wake of recent market volatility driven by global tariff tensions, Australian shares are poised for a significant downturn, with ASX 200 futures indicating a sharp decline. Amidst this challenging environment, identifying undervalued stocks requires careful analysis of fundamentals and resilience to external economic pressures. Name Current Price Fair Value (Est) Discount (Est) Acrow (ASX:ACF) A$1.035 A$2.04 49.3% Nick Scali (ASX:NCK) A$15.01 A$28.70 47.7% GenusPlus Group (ASX:GNP) A$2.65 A$5.20 49% Environmental Group (ASX:EGL) A$0.24 A$0.47 49.4% PolyNovo (ASX:PNV) A$1.05 A$2.06 49.1% Amaero International (ASX:3DA) A$0.26 A$0.46 43.6% James Hardie Industries (ASX:JHX) A$34.84 A$60.84 42.7% SciDev (ASX:SDV) A$0.43 A$0.84 48.5% Integral Diagnostics (ASX:IDX) A$2.28 A$4.07 44% Pantoro (ASX:PNR) A$2.55 A$4.92 48.2% Click here to see the full list of 41 stocks from our Undervalued ASX Stocks Based On Cash Flows screener. Here's a peek at a few of the choices from the screener. Overview: Capricorn Metals Ltd is involved in the evaluation, exploration, development, and production of gold properties in Australia with a market cap of A$3.50 billion. Operations: The company's revenue primarily comes from its Karlawinda gold operations, generating A$379.47 million. Estimated Discount To Fair Value: 26.6% Capricorn Metals is trading at A$8.47, below its estimated fair value of A$11.54, suggesting it may be undervalued based on cash flows. Recent earnings results show sales increased to A$201.37 million for the half year ending December 2024, although net income decreased to A$43.11 million compared to the previous year. Despite this, revenue and earnings are forecasted to grow significantly faster than the market, with a high return on equity expected in three years. Our expertly prepared growth report on Capricorn Metals implies its future financial outlook may be stronger than recent results. Click here and access our complete balance sheet health report to understand the dynamics of Capricorn Metals. Overview: Nanosonics Limited is a global infection prevention company with a market capitalization of A$1.42 billion. Operations: The company generates revenue primarily from its Healthcare Equipment segment, which accounts for A$183.97 million. Estimated Discount To Fair Value: 34.3% Nanosonics is trading at A$4.64, below its estimated fair value of A$7.06, indicating potential undervaluation based on cash flows. Recent earnings show sales increased to A$93.6 million for H1 2025, with net income rising to A$9.76 million year-over-year. Revenue and earnings are forecasted to grow significantly faster than the market, though return on equity remains low in future projections. The company has also revised its revenue growth guidance upwards for early 2025. According our earnings growth report, there's an indication that Nanosonics might be ready to expand. Click to explore a detailed breakdown of our findings in Nanosonics' balance sheet health report. Overview: Sigma Healthcare Limited is a pharmaceutical wholesaler, distributor, and pharmacy franchisor operating in Australia and internationally with a market cap of A$33.36 billion. Operations: The company generates revenue primarily through its Wholesale and Retail Services Segment, which accounts for A$3.29 billion. Estimated Discount To Fair Value: 15.1% Sigma Healthcare, trading at A$2.89, is below its estimated fair value of A$3.4, suggesting it may be undervalued based on cash flows. Revenue is projected to grow 39.2% annually, outpacing the Australian market's 5.8%. Earnings are expected to increase by 15.3% per year but remain below significant growth levels and face substantial insider selling recently. Sigma's inclusion in major indices like S&P/ASX 100 highlights its market relevance despite these challenges. Our growth report here indicates Sigma Healthcare may be poised for an improving outlook. Navigate through the intricacies of Sigma Healthcare with our comprehensive financial health report here. Unlock more gems! Our Undervalued ASX Stocks Based On Cash Flows screener has unearthed 38 more companies for you to here to unveil our expertly curated list of 41 Undervalued ASX Stocks Based On Cash Flows. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:CMM ASX:NAN and ASX:SIG. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
03-04-2025
- Business
- Yahoo
ASX Stocks That May Be Trading Below Fair Value Estimates In April 2025
As the Australian market experiences fluctuations, with the ASX200 closing down 0.94% at 7,859.7 points and sectors like IT and Energy leading declines, investors are increasingly focused on identifying stocks that may be trading below their fair value estimates. In such a volatile environment, recognizing undervalued stocks can offer potential opportunities for those looking to capitalize on discrepancies between current market prices and intrinsic value assessments. Name Current Price Fair Value (Est) Discount (Est) Acrow (ASX:ACF) A$1.065 A$1.97 45.8% Nido Education (ASX:NDO) A$0.78 A$1.56 49.9% Nick Scali (ASX:NCK) A$15.50 A$27.27 43.2% Amaero International (ASX:3DA) A$0.25 A$0.44 43.5% PolyNovo (ASX:PNV) A$1.10 A$2.11 47.8% Environmental Group (ASX:EGL) A$0.25 A$0.46 45.6% Charter Hall Group (ASX:CHC) A$16.50 A$31.87 48.2% SciDev (ASX:SDV) A$0.43 A$0.82 47.3% Genetic Signatures (ASX:GSS) A$0.475 A$0.88 45.9% Pantoro (ASX:PNR) A$2.55 A$4.82 47.1% Click here to see the full list of 41 stocks from our Undervalued ASX Stocks Based On Cash Flows screener. Here we highlight a subset of our preferred stocks from the screener. Overview: Genesis Minerals Limited is involved in the exploration, production, and development of gold deposits in Western Australia with a market cap of A$4.18 billion. Operations: The company generates revenue of A$561.40 million from its mineral production, exploration, and development activities in Western Australia. Estimated Discount To Fair Value: 16.2% Genesis Minerals has shown strong growth, with half-year sales reaching A$338.73 million, up from A$215.92 million the previous year, and net income rising to A$59.8 million. The company updated its 2025 production guidance to 190,000-210,000 oz of gold. Trading at approximately 16.2% below fair value (A$3.7 vs estimated A$4.41), Genesis is undervalued based on cash flows with earnings projected to grow significantly at over 20% annually for the next three years. Our growth report here indicates Genesis Minerals may be poised for an improving outlook. Get an in-depth perspective on Genesis Minerals' balance sheet by reading our health report here. Overview: GenusPlus Group Ltd operates in Australia, focusing on the installation, construction, and maintenance of power and communication systems, with a market cap of A$490.11 million. Operations: The company's revenue segments are comprised of Industrial at A$187.56 million, Communication at A$86.02 million, and Infrastructure at A$372.42 million. Estimated Discount To Fair Value: 15.4% GenusPlus Group appears undervalued, trading at 15.4% below its fair value estimate of A$3.21 with a current price of A$2.72. Recent earnings show strong performance, with half-year sales rising to A$332.87 million from A$249.96 million and net income increasing to A$13.7 million year-over-year. Earnings are projected to grow over 20% annually for the next three years, outpacing the broader Australian market's growth expectations and supporting its undervaluation based on cash flows. In light of our recent growth report, it seems possible that GenusPlus Group's financial performance will exceed current levels. Unlock comprehensive insights into our analysis of GenusPlus Group stock in this financial health report. Overview: Lovisa Holdings Limited operates in the retail sector, focusing on the sale of fashion jewelry and accessories, with a market capitalization of A$2.55 billion. Operations: The company's revenue primarily comes from the retail sale of fashion jewelry and accessories, amounting to A$731.57 million. Estimated Discount To Fair Value: 10.8% Lovisa Holdings is trading at A$23.04, slightly below its fair value estimate of A$25.82, representing a modest undervaluation based on cash flows. The company reported half-year sales of A$405.93 million and net income of A$56.93 million, showing year-over-year growth. Earnings are forecast to grow at 15.7% annually, surpassing the Australian market's average growth rate of 11.8%. However, Lovisa faces legal challenges due to alleged staff underpayment issues from 2019-2025, which could impact future financials. Our earnings growth report unveils the potential for significant increases in Lovisa Holdings' future results. Take a closer look at Lovisa Holdings' balance sheet health here in our report. Access the full spectrum of 41 Undervalued ASX Stocks Based On Cash Flows by clicking on this link. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:GMD ASX:GNP and ASX:LOV. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
03-04-2025
- Business
- Yahoo
ASX Stocks That May Be Trading Below Fair Value Estimates In April 2025
As the Australian market experiences fluctuations, with the ASX200 closing down 0.94% at 7,859.7 points and sectors like IT and Energy leading declines, investors are increasingly focused on identifying stocks that may be trading below their fair value estimates. In such a volatile environment, recognizing undervalued stocks can offer potential opportunities for those looking to capitalize on discrepancies between current market prices and intrinsic value assessments. Name Current Price Fair Value (Est) Discount (Est) Acrow (ASX:ACF) A$1.065 A$1.97 45.8% Nido Education (ASX:NDO) A$0.78 A$1.56 49.9% Nick Scali (ASX:NCK) A$15.50 A$27.27 43.2% Amaero International (ASX:3DA) A$0.25 A$0.44 43.5% PolyNovo (ASX:PNV) A$1.10 A$2.11 47.8% Environmental Group (ASX:EGL) A$0.25 A$0.46 45.6% Charter Hall Group (ASX:CHC) A$16.50 A$31.87 48.2% SciDev (ASX:SDV) A$0.43 A$0.82 47.3% Genetic Signatures (ASX:GSS) A$0.475 A$0.88 45.9% Pantoro (ASX:PNR) A$2.55 A$4.82 47.1% Click here to see the full list of 41 stocks from our Undervalued ASX Stocks Based On Cash Flows screener. Here we highlight a subset of our preferred stocks from the screener. Overview: Genesis Minerals Limited is involved in the exploration, production, and development of gold deposits in Western Australia with a market cap of A$4.18 billion. Operations: The company generates revenue of A$561.40 million from its mineral production, exploration, and development activities in Western Australia. Estimated Discount To Fair Value: 16.2% Genesis Minerals has shown strong growth, with half-year sales reaching A$338.73 million, up from A$215.92 million the previous year, and net income rising to A$59.8 million. The company updated its 2025 production guidance to 190,000-210,000 oz of gold. Trading at approximately 16.2% below fair value (A$3.7 vs estimated A$4.41), Genesis is undervalued based on cash flows with earnings projected to grow significantly at over 20% annually for the next three years. Our growth report here indicates Genesis Minerals may be poised for an improving outlook. Get an in-depth perspective on Genesis Minerals' balance sheet by reading our health report here. Overview: GenusPlus Group Ltd operates in Australia, focusing on the installation, construction, and maintenance of power and communication systems, with a market cap of A$490.11 million. Operations: The company's revenue segments are comprised of Industrial at A$187.56 million, Communication at A$86.02 million, and Infrastructure at A$372.42 million. Estimated Discount To Fair Value: 15.4% GenusPlus Group appears undervalued, trading at 15.4% below its fair value estimate of A$3.21 with a current price of A$2.72. Recent earnings show strong performance, with half-year sales rising to A$332.87 million from A$249.96 million and net income increasing to A$13.7 million year-over-year. Earnings are projected to grow over 20% annually for the next three years, outpacing the broader Australian market's growth expectations and supporting its undervaluation based on cash flows. In light of our recent growth report, it seems possible that GenusPlus Group's financial performance will exceed current levels. Unlock comprehensive insights into our analysis of GenusPlus Group stock in this financial health report. Overview: Lovisa Holdings Limited operates in the retail sector, focusing on the sale of fashion jewelry and accessories, with a market capitalization of A$2.55 billion. Operations: The company's revenue primarily comes from the retail sale of fashion jewelry and accessories, amounting to A$731.57 million. Estimated Discount To Fair Value: 10.8% Lovisa Holdings is trading at A$23.04, slightly below its fair value estimate of A$25.82, representing a modest undervaluation based on cash flows. The company reported half-year sales of A$405.93 million and net income of A$56.93 million, showing year-over-year growth. Earnings are forecast to grow at 15.7% annually, surpassing the Australian market's average growth rate of 11.8%. However, Lovisa faces legal challenges due to alleged staff underpayment issues from 2019-2025, which could impact future financials. Our earnings growth report unveils the potential for significant increases in Lovisa Holdings' future results. Take a closer look at Lovisa Holdings' balance sheet health here in our report. Access the full spectrum of 41 Undervalued ASX Stocks Based On Cash Flows by clicking on this link. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:GMD ASX:GNP and ASX:LOV. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
